Haasner Dirk 4
4 · Ovid Therapeutics Inc. · Filed Aug 29, 2018
Insider Transaction Report
Form 4
Haasner Dirk
SVP, Global Regulatory Affairs
Transactions
- Award
Employee Stock Option (right to buy)
2018-08-27+22,500→ 22,500 totalExercise: $6.40Exp: 2028-08-27→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]The option, representing a right to purchase a total of 22,500 shares becomes exercisable in two equal annual installments beginning on August 27, 2019, subject to the Reporting Person's continued service through each such date.